$9.95 Billion is the total value of BAIN CAPITAL INVESTORS LLC's 13 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATTO | New | ATENTO S A | $654,797,000 | – | 62,660,015 | +100.0% | 7.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Partners IX, L.P. #1
- Bain Capital (OSI) IX, L.P. #2
- Bain Capital (OSI) IX Coinvestment, L.P. #3
- Bain Capital Fund IX, L.P. #4
- Bain Capital Fund IX, LLC #5
- Bain Capital Partners X, L.P. #6
- Bain Capital Fund X, L.P. #7
- Bain Capital Integral Investors 2008, L.P. #8
- Bain Capital Partners Europe III, L.P. #9
- Bain Capital Europe Fund III, L.P. #10
- Bain Capital Everest Manager S.a.r.l. #11
- Bain Capital Everest Manager Holding SCA #12
- Bain Capital Partners VII, L.P. #13
- Bain Capital Fund VII, L.P. #14
- Bain Capital Fund VII, LLC #15
- Bain Capital VII Coinvestment Fund, L.P. #16
- Bain Capital VII Coinvestment Fund, LLC #17
- UWW Holdings, LLC #18
- Bain Capital Integral Investors 2006, LLC #19
- Bain Capital Integral Investors, LLC #20
- Bain Capital Partners Asia II, L.P. #21
- Glory Investments A Limited #22
- Glory Investments B Limited #23
- Atalaya Luxco S.a.r.l. #24
- Atalaya Luxco Topco S.C.A. #25
- Atalaya PIKco S.a.r.l. #26
- Atalaya Luxco PIKco SCA #27
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICHAELS COS INC | 27 | Q1 2021 | 45.7% |
| GENPACT LIMITED | 26 | Q3 2019 | 43.3% |
| VERITIV CORP | 26 | Q4 2020 | 7.1% |
| SURGERY PARTNERS INC | 25 | Q3 2023 | 54.6% |
| ATENTO S A | 25 | Q4 2020 | 14.1% |
| BRIGHT HORIZONS FAM SOL IN D | 19 | Q4 2017 | 18.4% |
| QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 15.1% |
| IQVIA HLDGS INC | 16 | Q3 2021 | 17.2% |
| VONAGE HLDGS CORP | 13 | Q2 2016 | 0.0% |
| CEREVEL THERAPEUTICS HLDNG, INC. | 12 | Q3 2023 | 42.1% |
View BAIN CAPITAL INVESTORS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 4 | 2023-12-21 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-18 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-06 |
| 4 | 2023-06-12 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 4 | 2022-11-23 |
View BAIN CAPITAL INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.